• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

One of Tesla’s biggest bulls ‘disappointed’ after Robotaxi event

by October 11, 2024
written by October 11, 2024

Investing.com — Morgan Stanley analysts expressed disappointment following Tesla (NASDAQ:TSLA)’s highly anticipated “We, Robot” event, highlighting a lack of critical details regarding Full Self-Driving (FSD) technology, ride-share economics, and a go-to-market strategy for autonomous vehicles.

Tesla shares are down more than 8% in early Friday trading, with many analysts noting the lack of details included in the event.

Tesla showcased its expected “cybercab” during the event, but Morgan Stanley noted that the presentation failed to provide significant new information. The research firm has been one of the biggest Tesla bulls on the Street.

“We were overall disappointed with the substance and detail of the presentation,” analysts said in a note.

Heading into the event, Morgan Stanley had anticipated key updates on Tesla’s FSD system, such as quantifiable improvements in terms of miles without disengagement, but these details were missing.

The firm also expected insights into the go-to-market strategy for Tesla’s supervised and unsupervised ride-sharing services, including economic analysis and total addressable market (TAM) estimates.

“We had expected at least some incremental information around the ‘rate of change’ of the FSD system,” they explained.

Moreover, Morgan Stanley said the event offered no meaningful discussion of Tesla’s partnership with xAI or any potential updates on Tesla’s “Master Plan 4,” leaving the analysts with the sense that the event did not significantly advance Tesla’s narrative as an AI company.

As a result, Morgan Stanley “anticipates TSLA to be under pressure following the event.” Despite the assessment, Morgan Stanley maintained an Overweight rating on Tesla shares.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Tesla shares slip as analysts flag lack of details at “Cybercab” robotaxi event
next post
Tesla and JP Morgan lead Friday’s morning market cap stock movers

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • American Eagle shares plunge 17% after it withdraws guidance, writes off $75 million in inventory

      May 14, 2025
    • Fintech company Chime files for Nasdaq IPO

      May 14, 2025
    • Father and son fraudsters sentenced in case of $100 million New Jersey deli

      May 13, 2025
    • UnitedHealth CEO suddenly steps down for ‘personal reasons’

      May 13, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (459)
    • Stock (6,426)

    Latest News

    • American Eagle shares plunge 17% after it withdraws guidance, writes off $75 million in inventory
    • Fintech company Chime files for Nasdaq IPO

    Popular News

    • France’s CAC 40 finishes choppy session unchanged as investors brace for government collapse
    • Vanda Pharmaceuticals rejects Cycle Pharma’s second takeover offer

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy